IDEAS home Printed from https://ideas.repec.org/r/eee/jhecon/v10y1991i2p227-234.html

Conversion factor instability in international comparisons of health care expenditure

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Hartwig, Jochen, 2008. "What drives health care expenditure?--Baumol's model of 'unbalanced growth' revisited," Journal of Health Economics, Elsevier, vol. 27(3), pages 603-623, May.
  2. Potrafke, Niklas, 2010. "The growth of public health expenditures in OECD countries: Do government ideology and electoral motives matter?," Journal of Health Economics, Elsevier, vol. 29(6), pages 797-810, December.
  3. Tom Jefferson & Miranda Mugford & Alastair Gray & Vittorio Demicheli, 1996. "An exercise on the feasibility of carrying out secondary economic analyses," Health Economics, John Wiley & Sons, Ltd., vol. 5(2), pages 155-165, March.
  4. Robert S. Woodward & Le Wang, 2012. "The Oh‐So Straight And Narrow Path: Can The Health Care Expenditure Curve Be Bent?," Health Economics, John Wiley & Sons, Ltd., vol. 21(8), pages 1023-1029, August.
  5. Marc Saez & Carles Murillo, 1994. "Shared ‘features’ in prices: Income and price elasticities for health care expenditures," Health Economics, John Wiley & Sons, Ltd., vol. 3(4), pages 267-279, July.
  6. Hansen, Paul & King, Alan, 1996. "The determinants of health care expenditure: A cointegration approach," Journal of Health Economics, Elsevier, vol. 15(1), pages 127-137, February.
  7. Melberg, Hans Olav, 2011. "Some problems with international comparisons of health spending – and a suggestion about how to quantify the size of the problems," HERO Online Working Paper Series 2011:4, University of Oslo, Health Economics Research Programme.
  8. Joan Costa‐Font & Marin Gemmill & Gloria Rubert, 2011. "Biases in the healthcare luxury good hypothesis?: a meta‐regression analysis," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 174(1), pages 95-107, January.
  9. Lee, Junsoo & Tieslau, Margie & Strazicich, Mark C. & Jewell, Todd, 2008. "Corrigendum to "Stationarity of health expenditures and GDP: Evidence from panel unit root tests with heterogeneous structural breaks" [J. Health Econ. 22 (2003) 313-323]," Journal of Health Economics, Elsevier, vol. 27(4), pages 1141-1142, July.
  10. Bosello, Francesco & Roson, Roberto & Tol, Richard S.J., 2006. "Economy-wide estimates of the implications of climate change: Human health," Ecological Economics, Elsevier, vol. 58(3), pages 579-591, June.
  11. Dihel, Nora, 2005. "Impact of services barriers on effective rates of protection in agriculture and manufacturing," Conference papers 331387, Purdue University, Center for Global Trade Analysis, Global Trade Analysis Project.
  12. Jonas Schreyögg & Oliver Tiemann & Tom Stargardt & Reinhard Busse, 2008. "Cross‐country comparisons of costs: the use of episode‐specific transitive purchasing power parities with standardised cost categories," Health Economics, John Wiley & Sons, Ltd., vol. 17(S1), pages 95-103, January.
  13. Pierre‐Yves Crémieux & Pierre Ouellette & Caroline Pilon, 1999. "Health care spending as determinants of health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 8(7), pages 627-639, November.
  14. Mark Berger & Jodi Messer, 2002. "Public financing of health expenditures, insurance, and health outcomes," Applied Economics, Taylor & Francis Journals, vol. 34(17), pages 2105-2113.
  15. Carlos Murillo & Cyrille Piatecki & Marc Saez, 1993. "Health care expenditure and income in Europe," Health Economics, John Wiley & Sons, Ltd., vol. 2(2), pages 127-138, July.
  16. Tang, Chor Foon, 2010. "The determinants of health expenditure in Malaysia: A time series analysis," MPRA Paper 24356, University Library of Munich, Germany.
  17. Irfan Ullah & Alam Rehman & Farman Ullah Khan & Muhammad Haroon Shah & Faridoon Khan, 2020. "Nexus between trade, CO2 emissions, renewable energy, and health expenditure in Pakistan," International Journal of Health Planning and Management, Wiley Blackwell, vol. 35(4), pages 818-831, July.
  18. Gyimah-Brempong, Kwabena & Wilson, Mark, 2004. "Health human capital and economic growth in Sub-Saharan African and OECD countries," The Quarterly Review of Economics and Finance, Elsevier, vol. 44(2), pages 296-320, May.
  19. Zweifel Peter, 2007. "Das Sisyphus-Syndrom im Gesundheitswesen: Neue Evidenz / The Sisyphus Syndrome in Health: New Evidence," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 227(5-6), pages 660-678, October.
  20. Amiri, Arshia & Ventelou, Bruno, 2012. "Granger causality between total expenditure on health and GDP in OECD: Evidence from the Toda–Yamamoto approach," Economics Letters, Elsevier, vol. 116(3), pages 541-544.
  21. Pierre‐Yves Crémieux & Marie‐Claude Meilleur & Pierre Ouellette & Patrick Petit & Martin Zelder & Ken Potvin, 2005. "Public and private pharmaceutical spending as determinants of health outcomes in Canada," Health Economics, John Wiley & Sons, Ltd., vol. 14(2), pages 107-116, February.
  22. Francette Koechlin & Paul Konijn & Luca Lorenzoni & Paul Schreyer, 2017. "Comparing Hospitals and Health Prices and Volumes Across Countries: A New Approach," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 131(1), pages 43-64, March.
  23. Rodrigo Cerda, 2002. "Why does Health Share of Income Increase over Time?," Documentos de Trabajo 207, Instituto de Economia. Pontificia Universidad Católica de Chile..
  24. Sarah Wordsworth & Anne Ludbrook, 2005. "Comparing costing results in across country economic evaluations: the use of technology specific purchasing power parities," Health Economics, John Wiley & Sons, Ltd., vol. 14(1), pages 93-99, January.
  25. Mahlich Jörg & Sindern Jörn & Suppliet Moritz, 2015. "Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG," Perspektiven der Wirtschaftspolitik, De Gruyter, vol. 16(2), pages 164-172, June.
  26. Niklas Potrafke, 2012. "Political cycles and economic performance in OECD countries: empirical evidence from 1951–2006," Public Choice, Springer, vol. 150(1), pages 155-179, January.
  27. Xiaocang Xu & Haoran Yang & Chang Li, 2022. "Theoretical Model and Actual Characteristics of Air Pollution Affecting Health Cost: A Review," IJERPH, MDPI, vol. 19(6), pages 1-14, March.
  28. Mihaela TOMAZIU-TODOSIA & Iuliana- Claudia MIHALACHE & Felicia- Cătălina APETROI (RĂCOARE), 2020. "Financial resources - an important aspect of increasing the performance of the health care sector in Romania," CES Working Papers, Centre for European Studies, Alexandru Ioan Cuza University, vol. 12(1), pages 89-99, May.
  29. Peter Zweifel & Lukas Steinmann & Patrick Eugster, 2005. "The Sisyphus Syndrome in Health Revisited," International Journal of Health Economics and Management, Springer, vol. 5(2), pages 127-145, June.
  30. Ärshiya Ämiri & Mikael Linden, 2016. "Income and total expenditure on health in OECD countries: Evidence from panel data and Hsiao's version of Granger non-causality tests," Economics and Business Letters, Oviedo University Press, vol. 5(1), pages 1-9.
  31. Adeel Saleem & Ghulam Sarwar & Jahanzaib Sultan & Zulfiqar Ali, 2022. "Determinants of Public Healthcare Investment: Cointegration and Causality Evidence from Pakistan," Journal of Economic Impact, Science Impact Publishers, vol. 4(2), pages 01-13.
  32. Helmut Herwartz & Bernd Theilen, 2003. "The determinants of health care expenditure: testing pooling restrictions in small samples," Health Economics, John Wiley & Sons, Ltd., vol. 12(2), pages 113-124, February.
  33. Berta Rivera & Luis Currais, 2003. "The effect of health investment on growth: A causality analysis," International Advances in Economic Research, Springer;International Atlantic Economic Society, vol. 9(4), pages 312-323, November.
  34. Maureen Mölken & Eddy Doorslaer & M. Till, 1998. "Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma," PharmacoEconomics, Springer, vol. 14(6), pages 671-684, December.
  35. Blomqvist, A. G. & Carter, R. A. L., 1997. "Is health care really a luxury?," Journal of Health Economics, Elsevier, vol. 16(2), pages 207-229, April.
  36. Mujaheed Shaikh & Afschin Gandjour, 2019. "Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two‐step instrumental variables strategy," Health Economics, John Wiley & Sons, Ltd., vol. 28(1), pages 101-122, January.
  37. Johannes Schoder & Peter Zweifel, 2011. "Flat-of-the-curve medicine: a new perspective on the production of health," Health Economics Review, Springer, vol. 1(1), pages 1-10, December.
  38. Héctor Bellido & Lorena Olmos & Juan Antonio Román-Aso, 2019. "Do political factors influence public health expenditures? Evidence pre- and post-great recession," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 455-474, April.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.